Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Directed ratchet transport in starlike networks of driven damped pendula by localized symmetry-breaking-inducing excitations.

Physical review. E·2025
Same author

State of the art in EEG signal features of mindfulness-based treatments for chronic pain.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025
Same author

Cortico-muscular and cortico-cortical coherence changes resulting from Perampanel treatment in patients with cortical myoclonus.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2021
Same author

Quantitative Bias Analysis of misclassification in case-control studies: an example with Human Papillomavirus and Oropharyngeal Cancer.

Community dental health·2020
Same author

Undetected anteromedial coronoid fracture in elbow dislocation: A case report.

Trauma case reports·2018
Same author

[Complete removable denture retained by symphyseal implant].

Journal of stomatology, oral and maxillofacial surgery·2017

Related Experiment Video

Updated: May 18, 2026

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
06:06

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease

Published on: May 9, 2022

Amoxicillin prophylaxis in oral surgery.

M Sixou1, J Burban, N Lakhssassi

  • 1Department of Epidemiology, Faculty of Dentistry, Toulouse University, 3, Chemin des Maraîchers, 31400 Toulouse, France. cousty.s@chu-toulouse.fr

Revue De Stomatologie Et De Chirurgie Maxillo-Faciale
|October 6, 2012
PubMed
Summary

Prophylactic amoxicillin significantly reduced postoperative infections in complex oral surgery patients. This randomized trial found amoxicillin effective in preventing surgical site infections, particularly for third molar and avulsion procedures.

Related Experiment Videos

Last Updated: May 18, 2026

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
06:06

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease

Published on: May 9, 2022

Area of Science:

  • Oral and Maxillofacial Surgery
  • Infectious Disease Prevention
  • Clinical Pharmacology

Background:

  • Postoperative infection is a common complication following oral surgery.
  • No prior double-blind, randomized, placebo-controlled trials have evaluated amoxicillin prophylaxis for oral surgery.
  • This pilot study addresses the need for evidence-based prophylactic strategies.

Purpose of the Study:

  • To assess the efficacy of prophylactic amoxicillin (3g orally) versus placebo.
  • To determine the effectiveness of amoxicillin in preventing postoperative oral infections.
  • To provide data for future large-scale clinical trials.

Main Methods:

  • A 5-year, multicenter, randomized, double-blind, placebo-controlled clinical trial.
  • Inclusion of healthy patients undergoing complex oral surgery.
  • Intention-to-treat analysis for final results.

Main Results:

  • 286 patients were randomized to amoxicillin or placebo groups.
  • Postoperative infection occurred in 3/143 patients receiving amoxicillin versus 11/143 in the placebo group (P=0.001).
  • Amoxicillin prophylaxis demonstrated a hazard ratio of 0.27 (95% CI: 0.07-0.94).

Conclusions:

  • Prophylactic amoxicillin appears effective in preventing postoperative infections after complex oral surgery.
  • The benefit is particularly noted in procedures involving mandibular third molars and multiple avulsions.
  • Findings support amoxicillin as a potential preventative measure in specific oral surgical contexts.